Aligned Genetics Inc, formerly Logos Biosystems Inc, is a Korea-based company engaged in the manufacture and sale of medical equipment. The Company's products mainly consist of automated cell counters, such as LUNA, LUNA-FL, LUNA-STEM, LUNA-II, LUNA- YF, QUANTOM, tissue clearing systems, such as X-CLARITY, and digital cell imaging systems, such as iRiS.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
25/06/26	₩3,075.00	+1.65%	10,682
24/06/26	₩3,025.00	+1.51%	12,543
23/06/26	₩2,980.00	-5.99%	19,826
22/06/26	₩3,170.00	-5.93%	55,237
19/06/26	₩3,370.00	-0.15%	26,040

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Korea S.E. Other stock markets 25/06/2026			5-day change	1st Jan Change
3,075.00 ^KRW	+1.65%		-8.89%	-20.54%

11-14	ACS, BlackRock launch 2 billion euro data centre joint venture	RE
11-13	ACS, BlackRock to seal $27 billion data centre deal, report says	RE

Market Cap	43.23B 28.06M 24.65M 22.71M 21.23M 39.82M 2.65B 40.55M 272M 106M 1.31B 105M 103M 4.54B	P/E 2024	10.5x	P/E 2025	18.8x
Enterprise Value	43.12B 27.98M 24.58M 22.65M 21.18M 39.72M 2.64B 40.45M 272M 105M 1.3B 105M 103M 4.52B	EV / Sales 2024	1.83x	EV / Sales 2025	3.39x
Free-Float	57.99%	Yield 2024 *	-	Yield 2025	-

11-14	ACS, BlackRock launch 2 billion euro data centre joint venture	RE
11-13	ACS, BlackRock to seal $27 billion data centre deal, report says	RE
16/10/25	Macquarie confident in AI, data centre future after $40 billion Aligned sale	RE
12/09/25	Aligned Genetics Inc to acquire real estate worth 14 billion won	RE
21/07/25	Aligned Genetics, Inc.'s Equity Buyback announced on January 21, 2025 has with 320,622 shares, representing 2.24% for KRW 997.53 million.	CI
21/07/25	Tranche Update on Aligned Genetics, Inc.'s Equity Buyback Plan announced on January 21, 2025.	CI
21/07/25	Tranche Update on Aligned Genetics, Inc.'s Equity Buyback Plan announced on January 21, 2025.	CI
24/04/25	Tranche Update on Aligned Genetics, Inc.'s Equity Buyback Plan announced on January 21, 2025.	CI
21/01/25	Aligned Genetics, Inc. announces an Equity Buyback for KRW 1,000 million worth of its shares.	CI
21/01/25	Aligned Genetics, Inc. authorizes a Buyback Plan.	CI
01/11/16	Logos Biosystems, Inc. has completed an IPO in the amount of KRW 18.056448 billion.	CI
16/06/16	Logos Biosystems, Inc. has filed an IPO.	CI

11-14	ACS y BlackRock lanzan una empresa conjunta de centros de datos por valor de 2.000 millones de euros
11-13	ACS y BlackRock cerrarán un acuerdo de centros de datos por 27.000 millones de dólares, según medio

Aligned Genetics, Inc. Stock

Stocks

A238120

KR7238120000

Advanced Medical Equipment & Technology

Valuation: Aligned Genetics, Inc.

Chart: Aligned Genetics, Inc.

Latest news : Aligned Genetics, Inc.

News in other languages: Aligned Genetics, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Aligned Genetics, Inc.

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+1.65%
1 week	-8.89%
Current month	-16.89%
1 month	-21.66%
3 months	-30.11%
6 months	-21.36%
Current year	-20.54%

1 week	2,930	3,350
1 month	2,930	4,020
Current year	2,930	6,050
1 year	2,930	6,050
3 years	2,575	6,175
5 years	2,575	6,925
10 years	2,002.5	9,150

Manager	Title	Age	Since
Yun-chul Jung CEO	Chief Executive Officer	56	01/10/2008
Yeon-suk Jung PRN	Corporate Officer/Principal	53	01/03/2012
Keun-chang Cho PRN	Corporate Officer/Principal	58	01/10/2008

Director	Title	Age	Since
Keun-chang Cho BRD	Director/Board Member	58	01/10/2008
Yun-chul Jung BRD	Director/Board Member	56	01/10/2008
Yeon-suk Jung BRD	Director/Board Member	53	01/03/2012

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALIGNED GENETICS, INC.	+1.65%	-8.89%	-0.97%	-29.95%	28.06M
SARTORIUS AG	+4.92%	+6.03%	+7.57%	-25.57%	16.5B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-3.26%	-2.78%	+24.22%	+51.43%	1.52B
ECKERT & ZIEGLER SE	-1.03%	-0.77%	-30.90%	+25.35%	1.1B
QUIDELORTHO CORPORATION	+10.73%	-1.10%	-51.90%	-83.98%	922M
CONTEC MEDICAL SYSTEMS CO.,LTD	-3.65%	-5.09%	-22.99%	-52.21%	640M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-1.46%	+6.40%	-38.63%	-54.81%	587M
VAREX IMAGING CORPORATION	-0.77%	-2.28%	+26.57%	-54.71%	434M
REVENIO GROUP OYJ	+0.47%	+1.60%	-53.32%	-60.62%	385M
908 DEVICES INC.	+0.11%	+1.47%	+32.45%	+24.20%	340M
Average	+0.12%	-0.53%	-10.79%	-26.09%	2.25B
Weighted average by Cap.	-0.29%	+4.18%	+1.98%	-22.21%

	2024	2025
Net sales	15.78B 10.24M 9M 8.29M 7.75M 14.53M 966M 14.8M 99.44M 38.51M 476M 38.46M 37.61M 1.66B	16.02B 10.4M 9.13M 8.41M 7.87M 14.75M 981M 15.02M 101M 39.1M 484M 39.04M 38.18M 1.68B
Net income	4.13B 2.68M 2.35M 2.17M 2.03M 3.8M 253M 3.87M 26.02M 10.08M 125M 10.06M 9.84M 433M	2.91B 1.89M 1.66M 1.53M 1.43M 2.68M 178M 2.73M 18.35M 7.11M 87.9M 7.1M 6.94M 305M
Net Debt	-14.68B -9.53M -8.37M -7.71M -7.21M -13.52M -899M -13.77M -92.49M -35.82M -443M -35.77M -34.99M -1.54B	-113M -73.35K -64.43K -59.36K -55.5K -104K -6.92M -106K -712K -276K -3.41M -275K -269K -11.86M